Apollo Hospitals Enterprise has announced the execution of definitive agreements to acquire a 60 per cent stake in the leading classical Ayurveda hospital chain, AyurVAID, in a combination of primary and secondary capital infusion. 

The transaction consideration (including primary and secondary investment) is ~ Rs 26 crore. The primary investment will be used to upgrade existing centres, set up new centres, strengthen enterprise platforms, and for digital health initiatives. Beginning with a revenue estimate of over Rs 15 crore for FY 23, the target is to achieve Rs 100 crore in the next three years.

The collaboration will ensure that tailored treatment pathways and options are available for patients, who will be treated by a multi-disciplinary clinical team, spanning allopathy and Ayurveda. The teams will carry forward the shared belief of evidence-based practice. 

Apollo Hospitals’ acquisition of stake in AyurVAID is aimed at delivering a unique Co-Managed Care Model, offering appropriate integration between modern medicine and Ayurveda. The partnership will also strive to build path-breaking research in integrative medicine through clear, differentiated research methodology to establish credible evidence for Ayurveda’s safety and efficacy.